FDA clears Cerner's iPhone-friendly mobile fetal monitoring system

Wed, 11/14/2012 - 3:08pm
Mass Device

Cerner lands FDA clearance for its Cerner FetaLink+, a mobile maternal and fetal monitoring device that could help clinicians provide high level of care for patients.

Cerner logo

Kansas City, Mo.-based healthcare provider Cerner (NSDQ:CERN) received FDA clearance to market its mobile maternal and fetal monitoring system, called Cerner FetaLink+, a device that help clinicians monitor mothers and babies using iPads or iPhones.

The newly approved Cerner FetaLink+, which integrates with Cerner's PowerChart Touch iPad app, provides near real-time access to critical information about the status of patients and waveform data over time, according to the press release. 


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.